173 related articles for article (PubMed ID: 29463227)
1. Evaluating different breast tumor progression models using screening data.
Westvik ÅS; Weedon-Fekjær H; Mæhlen J; Liestøl K
BMC Cancer; 2018 Feb; 18(1):209. PubMed ID: 29463227
[TBL] [Abstract][Full Text] [Related]
2. Natural history of breast cancers detected in the Swedish mammography screening programme: a cohort study.
Zahl PH; Gøtzsche PC; Mæhlen J
Lancet Oncol; 2011 Nov; 12(12):1118-24. PubMed ID: 21996169
[TBL] [Abstract][Full Text] [Related]
3. [Incidence of breast cancer before and after implementation of mammography screening].
Hofvind S; Sørum R; Haldorsen T; Langmark F
Tidsskr Nor Laegeforen; 2006 Nov; 126(22):2935-8. PubMed ID: 17117191
[TBL] [Abstract][Full Text] [Related]
4. The natural history of invasive breast cancers detected by screening mammography.
Zahl PH; Maehlen J; Welch HG
Arch Intern Med; 2008 Nov; 168(21):2311-6. PubMed ID: 19029493
[TBL] [Abstract][Full Text] [Related]
5. Breast cancer incidence trends in Norway and estimates of overdiagnosis.
van Luijt PA; Heijnsdijk EA; van Ravesteyn NT; Hofvind S; de Koning HJ
J Med Screen; 2017 Jun; 24(2):83-91. PubMed ID: 27754936
[TBL] [Abstract][Full Text] [Related]
6. [Mammography screening in Rogaland--the first round].
Iversen BF; Eriksen L
Tidsskr Nor Laegeforen; 2000 Nov; 120(27):3241-5. PubMed ID: 11187161
[TBL] [Abstract][Full Text] [Related]
7. Overdiagnosis of invasive breast cancer due to mammography screening: results from the Norwegian screening program.
Kalager M; Adami HO; Bretthauer M; Tamimi RM
Ann Intern Med; 2012 Apr; 156(7):491-9. PubMed ID: 22473436
[TBL] [Abstract][Full Text] [Related]
8. Assessing the impact of screening mammography: Breast cancer incidence and mortality rates in Connecticut (1943-2002).
Anderson WF; Jatoi I; Devesa SS
Breast Cancer Res Treat; 2006 Oct; 99(3):333-40. PubMed ID: 16703451
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of the Norwegian breast cancer screening program.
van Luijt PA; Heijnsdijk EA; de Koning HJ
Int J Cancer; 2017 Feb; 140(4):833-840. PubMed ID: 27861849
[TBL] [Abstract][Full Text] [Related]
10. Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status.
Glass AG; Lacey JV; Carreon JD; Hoover RN
J Natl Cancer Inst; 2007 Aug; 99(15):1152-61. PubMed ID: 17652280
[TBL] [Abstract][Full Text] [Related]
11. Breast cancer incidence trends in Norway--explained by hormone therapy or mammographic screening?
Hofvind S; Sakshaug S; Ursin G; Graff-Iversen S
Int J Cancer; 2012 Jun; 130(12):2930-8. PubMed ID: 21732346
[TBL] [Abstract][Full Text] [Related]
12. The contribution of mammography screening to breast cancer incidence trends in the United States: an updated age-period-cohort model.
Gangnon RE; Sprague BL; Stout NK; Alagoz O; Weedon-Fekjær H; Holford TR; Trentham-Dietz A
Cancer Epidemiol Biomarkers Prev; 2015 Jun; 24(6):905-12. PubMed ID: 25787716
[TBL] [Abstract][Full Text] [Related]
13. Breast cancer mortality in Norway after the introduction of mammography screening.
Olsen AH; Lynge E; Njor SH; Kumle M; Waaseth M; Braaten T; Lund E
Int J Cancer; 2013 Jan; 132(1):208-14. PubMed ID: 22532175
[TBL] [Abstract][Full Text] [Related]
14. Comparative analysis of breast cancer mortality following mammography screening in Denmark and Norway.
Kalager M; Løberg M; Bretthauer M; Adami HO
Ann Oncol; 2014 Jun; 25(6):1137-43. PubMed ID: 24669012
[TBL] [Abstract][Full Text] [Related]
15. [Overdiagnosis in mammography screening].
Zahl PH; Maehlen J
Tidsskr Nor Laegeforen; 2004 Sep; 124(17):2238-9. PubMed ID: 15356688
[TBL] [Abstract][Full Text] [Related]
16. Reduction in breast cancer mortality from organized service screening with mammography: 1. Further confirmation with extended data.
Swedish Organised Service Screening Evaluation Group
Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):45-51. PubMed ID: 16434585
[TBL] [Abstract][Full Text] [Related]
17. Stage distribution of breast cancer diagnosed before and after implementation of population-based mammographic screening.
Hofvind S; Skaane P
Rofo; 2012 May; 184(5):437-42. PubMed ID: 22426937
[TBL] [Abstract][Full Text] [Related]
18. Results of intermediate measures from a population-based, randomized trial of mammographic screening prevalence and detection of breast carcinoma among Asian women: the Singapore Breast Screening Project.
Ng EH; Ng FC; Tan PH; Low SC; Chiang G; Tan KP; Seow A; Emmanuel S; Tan CH; Ho GH; Ng LT; Wilde CC
Cancer; 1998 Apr; 82(8):1521-8. PubMed ID: 9554530
[TBL] [Abstract][Full Text] [Related]
19. Understanding recent trends in incidence of invasive breast cancer in Norway: age-period-cohort analysis based on registry data on mammography screening and hormone treatment use.
Weedon-Fekjær H; Bakken K; Vatten LJ; Tretli S
BMJ; 2012 Jan; 344():e299. PubMed ID: 22290099
[TBL] [Abstract][Full Text] [Related]
20. [Tailored Breast Screening Trial (TBST)].
Paci E; Mantellini P; Giorgi Rossi P; Falini P; Puliti D;
Epidemiol Prev; 2013; 37(4-5):317-27. PubMed ID: 24293498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
